Zobrazeno 1 - 10
of 303
pro vyhledávání: '"Antiviral agents/therapeutic use"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Emily D. Meyer, Sandra Dudareva, Christian Kollan, Stefan Mauss, Heiner Wedemeyer, Daniel Schmidt, Ruth Zimmermann
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
Effectively treating hepatitis C viral (HCV) infections prevents sequelae and onward transmission. In Germany, HCV drug prescriptions have declined since 2015. During the COVID-19 pandemic, lockdowns impacted the access to HCV care services and HCV t
Externí odkaz:
https://doaj.org/article/882aabcf7a0349ddad4d6d71c12232a9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fátima Falcão, Carla Lopes, Erica Viegas, Rita Perez, Isabel Aldir, Helena Farinha, António Carvalho, Ana Mirco, Susana Marques, Tiago Bana e Costa, Ana Cláudia Miranda, Luís Lebre, Paula Peixe, Cristina Chagas, Kamal Mansinho, José Manuel Correia
Publikováno v:
Acta Médica Portuguesa, Vol 32, Iss 3, Pp 189-194 (2019)
Introduction: In late 2014, Portugal implemented a national program for the treatment of patients with chronic hepatitis C with directacting antiviral agents. This program has made Portugal one of the first European countries to implement a structure
Externí odkaz:
https://doaj.org/article/5039479f3eb4475ba327d65f1999a35d
Autor:
Bárbara Martins Saraiva, Ana Margarida Garcia, Tiago Milheiro Silva, Catarina Gouveia, Maria João Brito
Publikováno v:
Acta Médica Portuguesa, Vol 34, Iss 4 (2021)
Introduction: Coronavirus disease 2019, or COVID-19, in children is usually a mild disease, but severe illness has been reported. Currently, the therapy benefits of antiviral experimental drugs are still uncertain. The main aim of this study is to de
Externí odkaz:
https://doaj.org/article/48f9d1d56eae44bc90e0997b74b88139
Subtherapeutic Exposure of Ganciclovir in Children Despite Appropriate Dosing: A Short Communication
Autor:
Marfil, Sjanene, Märtson, Anne-Grete, Toren-Wielema, Marlous, Leer-Buter, Coretta van, Schölvinck, Elisabeth H, Alffenaar, Jan-Willem C, Touw, Daan J, Sturkenboom, Marieke G G
Publikováno v:
Therapeutic Drug Monitoring, 45(2), 269-272. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic drug monitoring (TDM) results for ganciclovir in 12 different treatment episodes showed large intraindividual and interindividual variabilities in the trough concentration and area under the 24-hour concentration-time curve (AUC24). Despi
Autor:
Azita H. Talasaz, Parham Sadeghipour, Kasra Mehdizadeh, Niloofar Khoshnam Rad, Behnood Bikdeli, Gregory Y. H. Lip, Job Harenberg
Publikováno v:
Talasaz, A H, Sadeghipour, P, Mehdizadeh, K, Khoshnam Rad, N, Bikdeli, B, Lip, G Y H & Harenberg, J 2023, ' Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19 : Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals ', Thrombosis and Haemostasis, vol. 123, no. 2, pp. 186-191 . https://doi.org/10.1055/a-1956-9641
Data suggest that coronavirus disease 2019 (COVID-19) results in a prothrombotic state leading to arterial and venous thromboses. Vaccination, novel antiviral drugs, and emerging variants have changed the course of the disease in many ways; however,
Autor:
National Research Council, Division on Earth and Life Studies, Board on Life Sciences, Committee on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication
Exploring the Role of Antiviral Drugs in the Eradication of Polio: Workshop Report, is a report of a workshop in which experts evaluated whether an antiviral drug against poliovirus would be helpful in the final stages of the global polio eradication
Publikováno v:
Revue medicale suisse, vol. 19, no. 822, pp. 726-730
Cytomegalovirus (CMV) infection remains a significant infectious complication after transplantation. In this article, we summarize the recent advances in the management of CMV infection in solid-organ and hematopoietic stem-cell transplant recipients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::3be0f2b732ba102be8d0181cb6ee956b
https://serval.unil.ch/notice/serval:BIB_68BB8D4E0C80
https://serval.unil.ch/notice/serval:BIB_68BB8D4E0C80
Publikováno v:
Infection and Drug Resistance, Vol 2016, Iss Issue 1, Pp 101-117 (2016)
Urbano Sbarigia,1 Tom R Denee,1 Norris G Turner,2 George J Wan,3 Alan Morrison,4 Anna S Kaufman,4 Gary Rice,5 Geoffrey M Dusheiko6,7 1Janssen Pharmaceutica, Beerse, Belgium; 2Johnson & Johnson Health Care Systems, Inc., Titusville, NJ, 3Mallinckrodt
Externí odkaz:
https://doaj.org/article/3cc36ad5cea94659a854ffc36357afe4